Metropolis Healthcare balance sheet

As of Mar 2026

Total assets: ₹2,138cr+14.5% on Mar 2025
Shareholders' equity: ₹1,525cr+14.2% on Mar 2025
Total debt: ₹18.7cr+32.0% on Mar 2025
Cash and investments: ₹195cr+79.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	215	190	156	137
	660	590	455	455
	531	497	386	355
	0.0	0.0	0.0	19.5
	195	0.0	0.0	0.0
	1.8	1.8	1.8	1.8
	20.6	30.9	24.8	16.6
	22.3	32.7	26.5	18.4
	7.2	40.6	35.2	6.9
	38.9	171	181	207
	1,669	1,521	1,239	1,199
	45.5	47.8	38.7	44.6
	141	69.2	53.1	13.1
	170	148	126	122
	54.8	39.5	62.6	68.8
	7.5	9.5	8.6	24.4
	12.7	7.3	6.3	14.1
	386	273	257	242
	37.2	24.6	20.3	15.9
	469	346	316	303
	2,138	1,867	1,555	1,502
Equity
	41.5	10.4	10.2	10.2
	1,472	1,321	1,086	978
	1,513	1,331	1,096	988
	11.4	3.7	3.1	2.5
	1,525	1,335	1,099	991
Liabilities
	0.0	5.3	0.0	28.6
	140	107	119	0.5
	140	112	119	29.2
	34.2	26.7	15.8	13.0
	106	99.5	75.1	78.2
	—	0.0	0.0	126
	279	238	210	246
	18.7	8.9	0.0	50.4
	129	126	99.4	94.1
	98.3	108	95.7	20.1
	246	243	195	165
	14.2	7.6	10.5	9.6
	46.3	20.6	16.3	9.3
	27.0	23.0	24.0	81.4
	334	294	246	265
	613	533	456	511
	2,138	1,867	1,555	1,502
Trade payables — MSME split
	7.2	5.3	—	—
	122	121	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

METROPOLIS₹553.85

Metropolis Healthcare Ltd.

· Pharma & Health

₹ CrorePeersLALPATHLAB VIJAYA THYROCARE MARKSANS PARKHOSPS JLHL RUBICON HCGMcap ₹11,483 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	137.2	155.9	190.3	215.3	215.3
+ Goodwill	454.7	454.7	589.9	660.2	660.2
+ Other Intangibles	355.3	386.3	496.6	530.8	530.8
+ Intangibles under Development	19.5	0.0	0.0	0.0	0.0
+ Investments (Equity Method)	0.0	0.0	0.0	194.7	194.7
+ Non-current Investments	1.8	1.8	1.8	1.8	1.8
+ Other Non-current Financial Assets	16.6	24.8	30.9	20.6	20.6
Non-current Financial Assets	18.4	26.5	32.7	22.3	22.3
+ Deferred Tax Assets	6.9	35.2	40.6	7.2	7.2
+ Other Non-current Assets	206.8	180.6	171.5	38.9	38.9
Total Non-current Assets	1,198.9	1,239.2	1,521.4	1,669.4	1,669.4
Current Assets
+ Inventories	44.6	38.7	47.8	45.5	45.5
+ Current Investments	13.1	53.1	69.2	140.6	140.6
+ Trade Receivables	121.9	126.3	147.9	170.3	170.3
+ Cash & Cash Equivalents	68.8	62.6	39.5	54.8	54.8
+ Other Bank Balances	24.4	8.6	9.5	7.5	7.5
+ Other Current Financial Assets	14.1	6.3	7.3	12.7	12.7
Current Financial Assets	242.2	256.9	273.5	385.9	385.9
+ Other Current Assets	15.9	20.3	24.6	37.2	37.2
Total Current Assets	302.7	315.8	345.9	468.6	468.6
Total Assets	1,501.6	1,555.1	1,867.3	2,138.1	2,138.1
Equity
+ Equity Share Capital	10.2	10.2	10.4	41.5	41.5
+ Other Equity / Reserves	978.0	1,085.9	1,320.6	1,471.7	1,471.7
Equity — Owners of Parent	988.2	1,096.2	1,331.0	1,513.2	1,513.2
+ Minority Interest	2.5	3.1	3.7	11.4	11.4
Total Equity	990.7	1,099.3	1,334.6	1,524.6	1,524.6
Liabilities
+ Borrowings — Non-current	28.6	0.0	5.3	0.0	0.0
+ Other Non-current Financial Liab	0.5	119.1	106.9	139.7	139.7
Non-current Financial Liabilities	29.2	119.1	112.2	139.7	139.7
+ Provisions — Non-current	13.0	15.8	26.7	34.2	34.2
+ Deferred Tax Liabilities	78.2	75.1	99.5	105.6	105.6
+ Other Non-current Liabilities	125.5	0.0	0.0	—	—
Non-current Liabilities	245.9	209.9	238.4	279.5	279.5
+ Borrowings — Current	50.4	0.0	8.9	18.7	18.7
+ Trade Payables	94.1	99.4	125.9	129.4	129.4
+ Other Current Financial Liab	20.1	95.7	108.3	98.3	98.3
Current Financial Liabilities	164.6	195.1	243.1	246.5	246.5
+ Provisions — Current	9.6	10.5	7.6	14.2	14.2
+ Current Tax Liabilities	9.3	16.3	20.6	46.3	46.3
+ Other Current Liabilities	81.4	24.0	23.0	27.0	27.0
Current Liabilities	265.0	245.9	294.3	334.0	334.0
Total Liabilities	510.9	455.8	532.7	613.5	613.5
Total Equity & Liabilities	1,501.6	1,555.1	1,867.3	2,138.1	2,138.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	5.3	7.2	7.2
+ Dues to Other Creditors — Current	—	—	120.6	122.2	122.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.